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Objective: small abdominal aortic aneurysms (AAAs) do rupture and only half of AAAs above 5 cm would have ruptured
unoperated. Furthermore, conservative treatment of AAAs may cause psychological side effects and impaired quality of
life. To optimise the indication and time for operation for AAAs, we analysed whether serum elastin peptides (EP),
procollagen-IIIN-terminal propeptide (PIIINP), and the initial AAA size could predict operation for AAAs in initially
conservatively treated AAA.
Material and methods: in 1994, 4404 65–73 year old males were invited to hospital-based screening for AAAs by
ultrasonography. Seventy-six percent attended. One hundred and forty-one (4.2%) had AAAs (def: +30 mm). Nineteen
were offered operation (AAA +50 mm), and 112 were followed with annual control scans for 1–5 years (mean 2.5 years).
Of these, 99 had their EP (ng/ml) and PIIINP (ng/ml) determined using ELISA and RIA techniques. Two observers and
one scanner were used.
Results: the mean expansion rate was 2.7 mm/year. The initial AAA size (r=0.46; 0.26–0.61), EP (r=0.31; 0.11–0.49),
and NPIIIP (r=0.24; 0.02–0.44) was independently significant associated to expansion rate in a multiple linear regression
analysis including the three mentioned variables. The multivariate formula could by ROC curve analysis predict cases
reaching 5 cm in diameter within 5 years with a sensitivity and specificity of 91% and 87%, respectively, increasing to
91% and 94%, respectively, by accepting a 2 mm variation in those measurements. Twenty-three were lost to follow up,
21 of these due to death or severe illness. Of these, seven would have been predicted to reach an AAA size recommendable
for surgery. If all 23 were included in the analysis, the sensitivity and specificity would have been 87% and 85%,
respectively.
Conclusion: a predictive model using EP, PIIINP, and initial AAA size seems capable of predicting nine out of 10
AAAs that will be operated on within 5 years. However, a larger sample size is needed for clinical recommendations.
Key Words: Abdominal aortic aneurysm; Natural history; Expansion; Mass screening; Surveillance; Elastin peptides;
Surgery.
Introduction the number of small AAAs diagnosed. A number of
these will expand to a size demanding operation, but
Previous reports have described an 0.0–0.5% annual the patients will then be older with increased risk at
rupture rate of abdominal aortic aneurysms (AAAs) operation or will eventually have developed a con-
below 5 cm in diameter,1–7 while AAAs above 5 cm traindication for operation. Finally, conservative treat-
found at autopsy have increased frequency of rupture ment of small AAAs has been shown to cause
with increasing AAA size; from 20–50% of AAAs with psychological stress.14,15 These problems may increase,
57 cm in diameter to 95% in AAAs above 10 cm in if screening for AAAs proves to be beneficial.15 There-
diameter.1,8,9 These autopsy reports have been con- fore, a more specific indication for operation would
firmed by clinical studies.3,5–7,10–13 Therefore the in- be desirable.
dication of operation is mainly determined by the size Elastin and collagen are the major matrix com-
of the AAA. However, small AAAs do occasionally ponents of the human abdominal aorta. In AAAs the
rupture, while some AAAs operated on would never structure and the amount of both matrix proteins is
have ruptured.1–13 Furthermore, increasing use of ultra- changed.16 Increased levels of elastase in aneurysmal
sonographic scanning and CT scanning have increased walls,16–19 and increased systemic levels of procollagen-
III-N-terminal propeptide (PIIINP) have been reported
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peptide (EP) levels could be a possible strong predictor ethics committee and reported to the central control
of Registers.of the expansion of small AAAs, even after adjustment
for AAA size.21 SPSS 10.0 was used for Pearson’s correlation ana-
lysis, multiple linear regression analyses, and elab-After 5 years of screening and surveillance of AAAs,
we have analysed further whether EP alone, or in oration of ROC curves. For analyses of the ROC curves
the null hypothesis was that the test had a performancecombination with PIIINP and initial AAA size, could
be a potential clinical useful predictor for operation similar to the diagonal line, i.e. the area under the
curve was 0.5. If the lowest 95% confidence limit forfor AAAs in initially conservatively treated AAAs.
the area under the curve was above 0.5, a significant
predictive test was said to be present.
Material and Methods
As a part of a randomised screening trial assessing Results
the cost effectiveness of screening for AAAs, 4404
65–73 year-old males were invited to B-mode- After 2 and 5 years, 16 and 24 AAAs, respectively,
ultrasonographic screening for AAA at their regional had expanded to more than 5 cm and were referred
hospital in 1994. Their mean age was 68.5 years (SD: for preoperative evaluation. The mean expansion rate
2.68). Of these, 3344 (76%) attended and were examined was 2.7 mm/year. Initial AAA size (r=0.46; 0.26–0.61),
by a doctor and a nurse, specially trained in ultra- EP (r=0.31; 0.11–0.49), and NPIIIP (r=0.24; 0.02–0.44)
sonography, who alternated between organising and was significantly correlated to mean annual expansion
registering the patients and performing the scans. rate (Table 1).
An AAA was defined as an anterior–posterior aortic All three variables continued to be significantly
diameter of 30 mm or more. AAAs of 5 cm or more associated with expansion in a multivariate linear
were referred to a vascular surgeon. AAAs of 3–4.9 cm regression analysis using the three variables as in-
were offered yearly follow-up examinations to check dependent variables and expansion rate as the de-
for expansion.22 pendent variable. The formula of the predicted
All patients with an AAA consulted the trial doctor expansion rate was:
for information, interview, examination, and a rescan.
Blood samples were taken within 10 days of the initial
Predicted expansion rate (mm/year)=scan. The sampling was performed by the nurse and
0.1731(initial AAA size(mm))+0.0088(EP(Ng/ml))trial doctor in order to handle each sample in a stand-
+0.3579(PIIINP(Ng/ml))6.968.ardised way. Serum was stored at −21 °C until ana-
lysis.
One hundred and forty-one men had an AAA diag- The ROC curves for predicting operation within 2
years of surveillance concerning EP, PIIINP, initialnosed at screening (4.2%), 19 were above 5 cm at the
diagnosis and were referred for surgery; the remaining AAA size, and the multivariate model showed that
the variables were statistically significant predictive87% cases were offered annual control scans. Of these,
112 cases have now been followed for 1–5 (mean 2.5) for expansion to a size recommendable for surgery,
except PIIINP. The multivariate model reached a sensi-years. Of these, data including blood samples were
complete in 99 cases (88%). tivity and specificity of 94% and 87%, respectively,
while the sensitivity and specificity concerning initialExpansion was calculated as the change in the an-
terior–posterior diameter during the whole ob- AAA size was 93% and 90%, respectively. Within the
first 2 years, nine were lost for follow-up. Seven ofservation period transformed to annual units. It was
in mean 2.7 mm/year (SD: 2.1). these were due to development of severe illness. None
of their AAAs were predicted to become 5 cm or moreThe inter-observer variation (2 SD) of the infrarenal
anterior-posterior aortic diameter was 1.7 mm.23 The within 2 years. The corresponding ROC curves for 2
years, excluding those lost for follow-up within theconcentration of elastin-peptides (EP) in serum was
determined using an inhibition type of ELISA per- first 2 years, showed again that all the variables were
statistically significantly predictive for expansion to aformed essentially as described earlier21 and initially
by Giro and Davidson.24 The intra- and inter-assay size recommendable for surgery, except PIIINP. The
predictive value of the multivariate model was un-coefficients of variation were 6 and 10%, respectively.
Standards and serum samples were analysed in du- affected, maintaining a sensitivity and specificity of
94% and 87%, respectively, while the sensitivity andplicates. The trial was approved by the local scientific
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Table 1. Correlation matrix concerning the variables used in the prediction of abdominal aortic aneurysms expanding to sizes
recommendable for surgery. Pearson’s correlation analysis (r). Confidence intervals listed in parentheses.
Expansion rate Initial AAA size S-elastin peptides S-PIIINP
(mm/year) (mm) (ng/ml) (ng/ml)
Expansion rate (mm/year) 0.48 0.33 0.24
(0.29–0.63) (0.12–0.51) (0.01–0.44)
Initial AAA size (mm) 0.48 0.24 0.09
(0.29–0.63) (0.00–0.44) (−0.14–0.30)
S-elastin peptides (ng/ml) 0.33 0.24 0.01
(0.12–0.51) (0.01–0.44) (−0.21–0.23)
S-PIIINP (g/ml) 0.24 0.09 0.01
(0.01–0.44) (−0.14–0.30) (−0.21–0.23)
0.00 1.00
1.00
1 – Specificity
S
en
si
ti
vi
ty
0.25
0.50
0.75
0.25 0.50 0.75
Source of the Curve
Reference line
Multivariate
prediction
S-elastin-peptides
(ng/ml)
Initial size
(mm)
S-procollagen
(ng/ml)
ROC Curve
Diagonal segments are produced by ties.
0.00 1.00
1.00
1 – Specificity
S
en
si
ti
vi
ty
0.25
0.50
0.75
0.25 0.50 0.75
Source of the Curve
Reference line
Multivariate
prediction
S-elastin-peptides
(ng/ml)
Initial size
(mm)
S-procollagen
(ng/ml)
ROC Curve
Diagonal segments are produced by ties.
Fig. 2. ROC curves for predicting operation within 5 years ofFig. 1. ROC curves for predicting operation within 2 years of
surveillance concerning EP, PIIINP, initial AAA size, and the mul- surveillance concerning EP, PIIINP, initial AAA size, and the multi-
variate model are shown concerning those followed for 5 yearstivariate model are shown concerning those followed for 2 years
excluding those lost for follow up within the first 2 years. excluding those lost for follow up within the first 5 years.
specificity concerning initial AAA size decreased to were statistically significantly predictive for expansion
83% and 87%, respectively (Fig. 1). to a size recommendable for surgery expect PIIINP.
The ROC curves for predicting operation within 5 The best predictive variable was the multivariate
years of surveillance concerning EP, PIIINP, initial model, reaching a sensitivity and specificity of 91%
AAA size, and the multivariate model showed again and 87%, respectively (Fig. 2), increasing to 91% and
that all variables were statistically significant pre- 94%, respectively, by accepting 2 mm of variation of
dictive for expansion to a size recommendable for the measurements. The sensitivity and specificity con-
surgery except PIIINP. The best predictive variable cerning initial AAA size was both 83%, increasing to
was the multivariate model, reaching a sensitivity and 89% and 91%, respectively, by accepting 2 mm of
specificity of 87% and 85%, while the sensitivity and variation of the measurements (Table 2).
specificity concerning initial AAA size was 82% and
79%, respectively.
Within the first 5 years, 23 were lost for follow-up.
Twenty-one of these were due to development of Discussion
severe illness. Seven of their AAA would have been
predicted to become 5 cm or more within 5 years. The The studied cohort were recruited from a randomised
screening study which addressed the costs and ef-ROC curves for predicting operation within 5 years of
surveillance concerning EP, PIIINP, initial AAA size, fectiveness of screening. If any, the potential benefits
seem five to six times greater in males compared toand the multivariate model concerning those followed
for 5 years, excluding those lost for follow-up within females. Consequently, only males were studied.
A retrospective study of 56 cases with AAA orthe first 5 years showed again that all the variables
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Table 2. Initial AAA size and multivariate model for predicting small abdominal aortic aneurysms expanding to 5 cm or more within
two or five years without and with acceptance of 2 mm variation of the measurements.
Model Years ±2 mm Sensitivity Specificity Predictive value of a Predictive value of a
positive test negative test
Initial AAA size 2 − 83% (59–96) 87% (74–95) 71% (48–89) 93% (81–99)
+ 85% (55–98) 97% (89–99) 85% (55–98) 97% (89–99)
Multivariate 2 − 94% (55–98) 87% (74–95) 73% (50–89) 98% (87–99)
+ 92% (64–99) 98% (91–99) 92% (94–99) 91% (91–99)
Initial AAA size 5 − 83% (61–95) 83% (65–84) 79% (58–93) 86% (68–96)
+ 89% (71–98) 91% (77–98) 89% (71–98) 91% (77–98)
Multivariate 5 − 91% (72–99) 87% (69–96) 84% (64–96) 93% (77–99)
+ 91% (70–99) 94% (81–99) 91% (70–99) 94% (81–99)
thoracic aortic aneurysm found that exponential mod- decision-making in the management of small AAAs
on the basis of sensitivity and specificity of 91% andels of expansion had a slightly better fit than linear
models.25 We have not been able to show better pre- 87%, respectively, increasing to 91% and 94%, re-
spectively, by accepting 2 mm of interobserver vari-dictive values by exponential models of growth rate
in this cohort. The explanation could be due to the ation of the measurements (Table 2).
It seems relevant to question whether the relativelyrelatively small AAA followed, the low interobserver
variation, or the lack of ‘‘rapid expansion’’ as indication small increase in the predictive value compared to the
predictive values of only using the initial AAA sizefor operation. A high interobserver variation even-
tually combined with rapid expansion as an indication worth the effort and cost needed is to measure the
additional two variables. However, our observed inter-for surgery tends to a falsely exponential growth pat-
tern just before referral for surgery. observer variation of 1.68 mm seems smaller than most
other studies,23,27–31 and furthermore the same scannerWe wanted to develop a simple model involving
the endpoints in the aortic degradation. The role of was used to make all the measurements. Consequently,
the predictive value of the initial AAA size could bechronic obstructive pulmonary disease and smoking
in aneurysmal progression and rupture must be overestimated compared with a situation where the
predictive model is generalised. The multivariatethrough the measured elastin and collagen meta-
bolism. However, potential mechanical factors such as model would be less sensitive for a higher inter-
observer variation concerning the diameter. Further-blood viscosity and blood pressure were not included.
We do not have viscosity data, and the role of hyper- more, by including elastin and collagen markers the
most metabolic active AAAs are predicted to have thetension is debatable. It is a risk factor for having
an AAA but blood pressure did not correlate with highest expansion rate. Such small AAAs may have
the highest risk of rupturing while they are still small.expansion in our cohort as in most other studies.21,22,26
Non-inflammatory and inflammatory AAA may be- Finally, the costs of the serological markers are lower
than £10 per patient.have differently; however, we did not find any with
clinical or ultrasonographic signs of inflammatory an- It also seems relevant to question whether the pre-
diction that 8–9 out of 10 AAAs that will be operatedeurysms and none of the aneurysms referred for sur-
gery showed retroperitoneal fibrosis. Nevertheless, we on within 5 years is sufficiently satisfactory, because
10–15% of the recommendable operations would haveassessed whether CRP correlated with expansion,
PIIINP or elastin peptides. No significant correlations to be carried out on patients with AAAs that would
not reach 5 cm in diameter within 5 years or wouldwere noticed.
A combination of markers of the elastin and collagen be lost for follow-up mainly due to death or severe
illness. However, a larger amount of those lost formatrix metabolism with the initial AAA size seem
logical because the prediction must depend on how follow-up because of severe illness or death may have
a high frequency of contraindications for surgery. Fur-close the AAA is from its goal (operation indication),
and the degree of the elastin degradation and the thermore, the risk of rupture is removed, their quality
of life normalised,14,15 and the operation could probablycompensatory collagen anabolism16 because structural
changes in these two matrix components are the main be performed at lower risk because of a lower age.
Finally, the application of a predictive tool may reducecomponents in the weakness of the aneurysmal wall.
Our results suggest a potential clinical useful pre- the psychological consequences concerning those that
are not predicted recommendable for surgery. In all,dictive tool based upon the metabolism of elastin
and collagen combined with the initial AAA size in we find the application of the tested predictive tool
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